BioSpace News Archive

AnPac Bio-Medical Science Co., Ltd. today announced that it has filed a provisional patent application on the use of AnPac Bio’s novel detection technology, methods and apparatus for coronavirus detection with the US Patent Trademark and Office

Copyright Clearance Center, Inc. (CCC), a leader in advancing copyright, accelerating knowledge, and powering innovation, announces the publishing unit of the Commonwealth Scientific and Industrial Research Organisation

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, announced its gout prophylaxis product, GLOPERBA® (colchicine), is now commercially available in pharmacies across the United States.

Debiopharm announced that the American Food and Drug Administration (FDA) has granted a Breakthrough Therapy Designation for Debio 1143, the most clinically advanced IAP antagonist, for the treatment of patients with confirmed diagnosis

Vycor Medical, Inc. (OTCQB: VYCO) Jose Romano, Chief of the Stroke Division at the University of Miami Miller School of Medicine, co-authored a recently published international study that shows that visual rehabilitation is effective for patients who have suffered vision loss related to stroke or traumatic brain injury.

GlaxoSmithKline plc (GSK) and Innoviva, Inc. (INVA) today announced the acceptance of a regulatory submission seeking an additional indication for the use of once-daily, single-inhaler triple therapy, Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol or FF/UMEC/VI) for the treatment of asthma in adults by the European Medicines Agency (EMA).

CMP Pharma, Inc. announced today that its Potassium Phosphates Injection, the first ever FDA approved injection.

- Datavant has hired Aden Fine as General Counsel and Chief Privacy Officer - Datavant has hired Dongting Yu, PhD, as Head of Security Engineering - David Shulkin (former Secretary of Veterans Affairs) and Andrew von Eschenbach (former FDA Commissioner and NCI Director) appointed to Datavant Advisory Board

The Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center, one of the largest hyperbaric medicine centers in the world, announced study results indicating its hyperbaric oxygen therapy (HBOT) protocols induce significant improvement in most cognitive domains of patients who suffered stroke – even months to years after the event.

Company achieves milestone, completes more than 300 COLORFUL COMMUNITIES projects since 2015